Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR–CML cell lines?

Por Rumjanek, Vivian M., Vidal, Raphael S., Maia, Raquel C.
Publicado em 2013

Towards Comprehension of the ABCB1/P-Glycoprotein Role in Chronic Myeloid Leukemia

Por Maia, Raquel C., Vasconcelos, Flavia C., Souza, Paloma S., Rumjanek, Vivian M.
Publicado no Molecules (2018)

Microparticles induce multifactorial resistance through oncogenic pathways independently of cancer cell type

Por de Souza, Paloma Silva, Cruz, André LS, Viola, João PB, Maia, Raquel C
Publicado no Cancer Sci (2015)

Compound A398, a Novel Podophyllotoxin Analogue: Cytotoxicity and Induction of Apoptosis in Human Leukemia Cells

Por Silveira, Alethéia L., Faheina-Martins, Glaúcia V., Maia, Raquel C., Araújo, Demetrius A. M.
Publicado em 2014

Analysis of survivin, XIAP and FoxM1 as potential chemoresistance factors in breast cancer cells

Por Moraes, Gabriela N, Vasconcelos, Flavia C, Delbue, Deborah, Silva, Karina L, Mognol, Giuliana P, Viola, João P, Maia, Raquel C
Publicado em 2013

Expression of the multidrug transporter P-glycoprotein is inversely related to that of apoptosis-associated endogenous TRAIL

Por Souza, Paloma S., Madigan, James P., Gillet, Jean-Pierre, Kapoor, Khyati, Ambudkar, Suresh V., Maia, Raquel C., Gottesman, Michael M., Fung, King Leung
Publicado no Exp Cell Res (2015)